NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 971 coverTHE CHROMAFFIN CELL: TRANSMITTER BIOSYNTHESIS, STORAGE, RELEASE, ACTIONS, AND INFORMATICS: 11th INTERNATIONAL SYMPOSIUM ON CHROMAFFIN CELL BIOLOGY Copyright © 2002 by the New York Academy of Sciences
description

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by GARLAND, E. M.
Articles by ROBERTSON, D.
Search for Related Content
PubMed
PubMed Citation
Articles by GARLAND, E. M.
Articles by ROBERTSON, D.
Annals of the New York Academy of Sciences 971:506-514 (2002)
© 2002 New York Academy of Sciences

Genetic Basis of Clinical Catecholamine Disorders

EMILY M. GARLANDa, MAUREEN K. HAHNa, TERRY P. KETCHa, NANCY R. KELLERa, CHUN-HYUNG KIMb, KWANG-SOO KIMb, ITALO BIAGGIONIa,c, JOHN R. SHANNONa,c, RANDY D. BLAKELYa AND DAVID ROBERTSONa,c,d

aDepartment of Pharmacology, cAutonomic Dysfunction Center, Department of Medicine, dDepartment of Neurology, Vanderbilt University, Nashville, Tennessee 37232, USA
bMolecular Neurobiology Laboratory, Harvard Medical School, Belmont, Massachusetts 02178, USA

Address for correspondence: David Robertson, M. D., Autonomic Dysfunction Center, AA3228 Medical Center North, Vanderbilt University, Nashville, TN 37232-2195. Voice: 615-343-6499; fax: 615-343-8649.
David.robertson{at}mcmail.vanderbilt.edu
Ann. N.Y. Acad. Sci. 971: 506-514 (2002).

Norepinephrine and epinephrine are critical determinants of minute-to-minute regulation of blood pressure. Here we review the characterization of two syndromes associated with a genetic abnormality in the noradrenergic pathway. In 1986, we reported a congenital syndrome of undetectable tissue and circulating levels of norepinephrine and epinephrine, elevated levels of dopamine, and absence of dopamine-ß-hydroxylase (DBH). These patients appeared with ptosis and severe orthostatic hypotension and lacked sympathetic noradrenergic function. In two persons with DBH deficiency, we identified seven novel polymorphisms. Both patients are compound heterozygotes for a variant that affects expression of DBH protein via impairment of splicing. Patient 1 also has a missense mutation in DBH exon 2, and patient 2 carries missense mutations in exons 1 and 6. Orthostatic intolerance is a common syndrome affecting young women, presenting with orthostatic tachycardia and symptoms of cerebral hypoperfusion on standing. We tested the hypothesis that abnormal norepinephrine transporter (NET) function might contribute to its etiology. In our proband, we found an elevated plasma norepinephrine with standing that was disproportionate to the increase in levels of dihydroxphenylglycol, as well as impaired norepinephrine clearance and tyramine resistance. Studies of NET gene structure revealed a coding mutation converting a conserved alanine residue in transmembrane domain 9 to proline. Analysis of the protein produced by the mutant cDNA demonstrated greater than 98% reduction in activity relative to normal. The finding of genetic mutations responsible for DBH deficiency and orthostatic intolerance leads us to believe that genetic causes of other autonomic disorders will be found, enabling us to design more effective therapeutic interventions.

Key Words: catecholamines • norepinephrine • dopamine-ß-hydroxylase • norepinephrine transporter • genetic • autonomic nervous system diseases • blood pressure • heart rate • posture • dopamine • deficiency • dysautonomia • autonomic disorders




This article has been cited by other articles:


Home page
Clin. Chem.Home page
K. Hyland
Clinical Utility of Monoamine Neurotransmitter Metabolite Analysis in Cerebrospinal Fluid
Clin. Chem., April 1, 2008; 54(4): 633 - 641.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. W. Schwartz, G. Novarino, D. W. Piston, and L. J. DeFelice
Substrate Binding Stoichiometry and Kinetics of the Norepinephrine Transporter
J. Biol. Chem., May 13, 2005; 280(19): 19177 - 19184.
[Abstract] [Full Text] [PDF]



footerLeft footerRight